去年，United-Guardian Inc表现最佳的业务板块Pharmaceutical实现营收6.23M美元。United States的营收贡献最高，去年达到8.14M美元。最近一个季度，截至2026-06-30，United-Guardian Inc表现最佳的业务板块Pharmaceutical实现营收1.47M美元。United States的营收贡献最高，达到2.57M美元。

业务

营业收入

占比

年报

年报

单季报

Pharmaceutical

Cosmetic Ingredients

Medical

Discounts and allowances

Industrial Products

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Pharmaceutical

6.23M(59.04%)

5.60M(45.99%)

5.89M(54.15%)

5.93M(46.69%)

4.74M(33.99%)

4.52M(41.13%)

5.24M(38.52%)

Cosmetic Ingredients

3.28M(31.11%)

5.82M(47.75%)

4.28M(39.35%)

5.39M(42.43%)

6.87M(49.34%)

4.27M(38.91%)

6.38M(46.94%)

Medical

2.11M(20.02%)

2.03M(16.65%)

1.75M(16.08%)

2.47M(19.46%)

2.17M(15.59%)

2.05M(18.69%)

2.97M(21.85%)

Discounts and allowances

-1.07M(-10.17%)

-1.27M(-10.39%)

-1.09M(-10.05%)

-1.21M(-9.51%)

--(--)

-1.15M(-8.49%)

Industrial Products

--(--)

51.59K(0.47%)

116.83K(0.92%)

150.39K(1.08%)

139.48K(1.27%)

161.14K(1.18%)

地区

营业收入

占比

年报

年报

单季报

United States

Other Countries

China

Canada

United Kingdom

India

France

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

United States

8.14M(77.20%)

10.18M(83.53%)

8.60M(79.02%)

9.54M(75.10%)

11.16M(80.11%)

8.80M(80.07%)

11.12M(81.76%)

11.94M(82.57%)

8.31M(77.14%)

6.57M(46.88%)

4.72M(35.12%)

4.58M(29.71%)

4.65M(33.62%)

5.81M(40.49%)

Other Countries

2.40M(22.80%)

2.01M(16.47%)

2.28M(20.98%)

3.16M(24.90%)

2.77M(19.89%)

2.19M(19.93%)

2.48M(18.24%)

2.52M(17.43%)

2.46M(22.86%)

3.19M(22.75%)

886.84K(6.59%)

1.79M(11.63%)

2.95M(21.34%)

2.81M(19.58%)

China

--(--)

4.19M(29.94%)

3.50M(26.03%)

3.52M(22.83%)

2.46M(17.81%)

2.14M(14.96%)

Canada

--(--)

60.12K(0.43%)

2.44M(18.12%)

3.39M(21.99%)

2.86M(20.69%)

2.55M(17.80%)

United Kingdom

--(--)

703.14K(5.23%)

846.73K(5.49%)

--(--)

India

--(--)

615.89K(4.58%)

431.01K(2.80%)

--(--)

France

--(--)

582.48K(4.33%)

856.28K(5.55%)

903.14K(6.53%)

1.03M(7.18%)